Optimisation of a PC12 cell-based in vitro stroke model for screening neuroprotective agents

Stroke causes death and disability globally but no neuroprotectant is approved for post-stroke neuronal injury. Neuroprotective compounds can be identified using oxygen glucose deprivation (OGD) of neuronal cells as an in vitro stroke model. Nerve growth factor (NGF)-differentiated PC12 pheochromocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, PinFen, Lim, William K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046774/
https://www.ncbi.nlm.nih.gov/pubmed/33854099
http://dx.doi.org/10.1038/s41598-021-87431-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046774/
https://www.ncbi.nlm.nih.gov/pubmed/33854099
http://dx.doi.org/10.1038/s41598-021-87431-4

Ejemplares similares